====== Beardsworth Consulting Group ======

{{ ::beardsworth.png?200|}}

**Beardsworth Consulting Group** was an American contract research organization (CRO) based in [[united_states:new_jersey:Flemington]], [[united_states:New Jersey]].

===== History =====

In June 2010, Beardsworth hired [[Alison Martin]] as the company's Scientific Advisor of Oncology and [[Robert Malone]] as Scientific Advisor of Vaccines.((//Martin and Malone join Beardsworth Consulting.// (2010, June 30). The Courier-News, 8. http://archive.today/2023.03.05-183739/https://www.newspapers.com/clip/114992006/dr-malone/))

On April 26, 2013, Beardsworth was acquired by [[TFS HealthScience]].((Otmani, M. (2013, May 20). //TFS acquires Beardsworth Consulting Group.// Nordic Life Science. https://web.archive.org/web/20220627170517/https://nordiclifescience.org/tfs-acquires-beardsworth-consulting-group/))

===== Organization =====

==== Personnel ====

Beardsworth's key personnel included:((//Key Personnel.// Beardsworth. Retrieved January 19, 2012, from https://archive.ph/HTZ5b))

^ Name  ^ Position  ^ Notes  ^
| [[Michael O'Brien]]  | President and CEO  | [[Allerion]], [[medical_technology_companies:Bionx Implants]], [[pharmaceutical_companies:Biosyn]], [[pharmaceutical_companies:Biocyte]], [[Deloitte]]  |
| [[Alison Martin]]  | Scientific Advisor of Oncology  | [[OncologyOne]], [[National Cancer Institute]] (NCI), [[Food and Drug Administration]] (FDA), [[Cancer Therapy Evaluation Program]] (CTEP), [[American Society of Clinical Oncology]] (ASCO), [[Melanoma Research Foundation]] (MRF)  |
| [[Robert Malone]]  | Medical Director for Vaccines  | [[pharmaceutical_companies:Vical]], [[pharmaceutical_companies:MentaGen]], [[pharmaceutical_companies:Intradigm]], [[pharmaceutical_companies:Solvay Biologicals]], [[pharmaceutical_companies:DynPort Vaccine Company]], [[Aeras Global TB Vaccine Foundation]], [[PATH]], [[pharmaceutical_companies:Iomai]], [[pharmaceutical_companies:VaxGen]], [[journals:Journal of Immune Based Therapies and Vaccines]]  |
| [[Art Gertel]]  | Vice President of Strategic Regulatory Consulting, Medical Writing, and QA  | [[OncologyOne]], [[pharmaceutical_companies:Schering-Plough]], [[pharmaceutical_companies:Roche]], [[iKnowMed]], [[American Medical Writers Association]] (AMWA), [[Drug Information Association]] (DIA), [[European Medical Writers Association]] (EMWA), [[Clinical Data Interchange Standards Consortium]] (CDISC)  |
| [[Dan Diaz]]  | Vice President of Business Development  | [[pharmaceutical_companies:Merrell Dow Pharmaceuticals]], [[pharmaceutical_companies:Marion Laboratories]], [[OncologyOne]]  |
| [[Evette Riegel]]  | Senior Director, Clinical Operations and Project Management  | [[IQVIA]], [[pharmaceutical_companies:Discovery Laboratories]], [[pharmaceutical_companies:ViroPharma]] and [[pharmaceutical_companies:Wyeth]]  |
| [[Linda Diehl Martz]]  | Executive Director of Clinical Data Management and Project Director  | [[pharmaceutical_companies:Johnson & Johnson]], [[Overlook Hospital]]  |
| [[Sue Dabrowski]]  | Executive Director of Human Resources  | [[Fragomen, Del Rey, Bernsen & Loewy]], [[Keane]], [[AGS Information Services]], [[Society of Human Resource Management]], [[Wharton School of the University of Pennsylvania]], [[International Foundation of Employee Benefit Plans]]  |
| [[Jocelyn Colquhoun]]  | Director of Medical Writing  | [[pharmaceutical_companies:Schering-Plough|Schering-Plough Research Institute]], [[IQVIA]], [[pharmaceutical_companies:Roberts Pharmaceutical Corporation]]  |
| [[William Cooper]]  | Senior Biostatistician  | [[pharmaceutical_companies:Bristol-Myers Squibb]], [[Revlon Health Care Group]]  |
| [[Vincent DiBianca]]  | Executive Management Team and Advisory Board  | [[Deloitte]], [[DiBianca Berkman Group]], [[Computer Sciences Corporation]] (CSC)  |
| [[Richard Constantine]]  | Executive Management Team and Advisory Board  | [[Deloitte]]  |